Recent Company News

• 09:04 AM ET Mar 31, 2026
  

  FDA identifies cases of serious liver injury in patients taking Amgen's Tavneos for severe active anti-neutrophil cytoplasmic autoantibody associated vasculitis ($349.00, 0.00)

• 12:01 AM ET Mar 19, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (85 total)

• 11:59 PM ET Mar 16, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (43 total)

• 11:59 PM ET Mar 12, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (67 total)

• 11:55 PM ET Mar 11, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (63 total)

• 09:16 AM ET Mar 10, 2026
  

  StreetAccount Sector Summary - Real Estate Pre Market

• 11:01 AM ET Mar 09, 2026
  

  CSL announces expansion of Illinois plasma therapy manufacturing facility

• 11:57 PM ET Mar 08, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (75 total)

• 05:05 PM ET Mar 06, 2026
  

  StreetAccount Summary: Notable Drug Events expected for the week of 8-Mar

• 10:57 PM ET Mar 03, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (47 total)